Page last updated: 2024-08-25

1-benzylpiperazine and Intraocular Pressure

1-benzylpiperazine has been researched along with Intraocular Pressure in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bartolucci, G; Bonardi, A; Bua, S; Chiapponi, D; Chiaramonte, N; Dei, S; Durante, M; Ferraroni, M; Gratteri, P; Lucarini, L; Manetti, D; Masini, E; Nocentini, A; Romanelli, MN; Supuran, CT; Teodori, E1

Other Studies

1 other study(ies) available for 1-benzylpiperazine and Intraocular Pressure

ArticleYear
2-Benzylpiperazine: A new scaffold for potent human carbonic anhydrase inhibitors. Synthesis, enzyme inhibition, enantioselectivity, computational and crystallographic studies and in vivo activity for a new class of intraocular pressure lowering agents.
    European journal of medicinal chemistry, 2018, May-10, Volume: 151

    Topics: Animals; Carbonic Anhydrase I; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IV; Carbonic Anhydrase IX; Carbonic Anhydrases; Crystallography, X-Ray; Glaucoma; Humans; Intraocular Pressure; Male; Molecular Docking Simulation; Piperazines; Rabbits; Stereoisomerism

2018